Dinaciclib
-
Catalog number9537-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol; SCH-727965
-
DescriptionDinaciclib is a potent and selective cyclin-dependent kinase (CDK) inhibitor displaying selectivity for CDK1, CDK2, CDK5 and CDK9 with IC₅₀ values of 3, 1, 1 and 4 nM respectively. It has been shown to inhibit DNA synthesis by blocking thymidine incorporation in A2780 ovarian cancer cells with an IC₅₀ value of 4 nM.
-
CAS Number779353-01-4
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₈N₆O₂
-
Molecular Weight396.49
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>20 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent CDK inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID46926350
-
SMILESCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO
-
InChiInChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1
-
InChi KeyPIMQWRZWLQKKBJ-SFHVURJKSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameDinaciclib
-
Alternative nameDinaciclib
-